Document is current
Any future updates will be listed below
-
Authors
Kolstad, Kathleen D.
Khatri, Avani
Donato, Michele
Chang, Sarah E.
Li, Shufeng
Steen, Virginia D.
Utz, Paul J.
Khatri, Purvesh
Chung, Lorinda http://orcid.org/0000-0003-0072-6939
-
Funding
Funding for this research was provided by:
Scleroderma Research Foundation
Translational Research and Applied Medicine (TRAM) Pilot Grant Program
- License Information
-
More Information
Article History
Received: 28 September 2021
Accepted: 1 February 2022
First Online: 9 February 2022
Declarations
:
: The Institutional Review Board at 22 participating US centers approved the PHAROS protocol and patients provided written informed consent prior to enrollment.
: Not applicable
: Dr. Chung has received consulting fees and/or served on the Advisory Board for Eicos Sciences, Boehringer Ingelheim, Genentech, Kyverna, and Mitsubishi Tanabe. She has served on the Data Monitoring Safety Board for Reata. She receives funding support from Scleroderma Research Foundation. No other authors have conflicts of interest to disclose relevant to this manuscript.
